NCT01711762

A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers

A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0973 Following Single Oral Dose Administration in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Genentech, Inc. · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This open-label, non-randomized study will assess the absorption, metabolism, and excretion of radioactive-labeled \[14C\]-GDC-0973 in healthy male volunteers. Volunteers will receive a single dose of \[14C\]-GDC-0973.

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	GDC-0973	Single oral dose of \[14C\]-GDC-0973

Timeline

• Start date: 2012-09-01
• Primary completion: 2012-09-01
• Completion: 2012-09-01
• First posted: 2012-10-22
• Last updated: 2016-11-02

Locations

1 site across 1 country: United States